Skip to main content

Bioinformatics Buh-bye, Australian Roots

Premium

Less than a year after the merger between eBioinformatics and Empatheon created Entigen, the company has closed its Sydney, Australia, office and laid off all its employees in Australia.

A source at Entigen says that a “substantial number” of US employees were also let go. The source added that employees were told the company had been close to securing a new round of funding, but investors pulled out in the wake of the September 11 attack, leaving Entigen out of cash.

The company had tried to bulk up its coffers last fall by changing its online bioinformatics service, BioNavigator, from pay-as-you-go to subscription-based. President Howard Goldstein says this was part of a plan to shift away from the original online model toward in-house installations of BioNavigator behind company firewalls.

— Bernadette Toner

 

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.